The race is on between Kura Oncology and Syndax Pharmaceuticals.
On Wednesday, Kura and its partner Kyowa Kirin announced that their targeted treatment ziftomenib succeeded …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Pii’s addition to Jabil’s portfolio brings scientific expertise and a range of pharmaceutical development and manufacturing services. Credit: Jabil Inc./Business Wire. Jabil has acquired contract
What You Should Know: – The year 2023 saw a stark shift in the digital health funding landscape, according to Rock Health’s annual year-end digital
The New York Times profiled Joy Milne, a super-smeller who can detect Parkinson’s disease and the co-author of several papers on the topic. Cold and